Three pharmaceutical groups filed federal lawsuits against North Dakota’s recently passed 340B law, the North Dakota Monitor reported Aug. 26.  House Bill 1473 was signed into law by Gov. Kelly Armstrong earlier this year, making it a class B misdemeanor…

Here are five new drug shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists. 

Pfizer is laying off 100 workers in Bothell, Wash., according to a WARN notice filed Aug. 25.  The Bothell, Wash.-based facility previously served as the headquarters for Seagen, a cancer therapeutics company Pfizer acquired for $43 billion in 2023. The…

Labels for GLP-1 medications, like Ozempic and Mounjaro, might see more approved uses as researchers study the drugs' effects on sleep apnea, dementia and other health issues. Meanwhile, oncologists are looking at a GLP-1 role in cancer care.

Eli Lilly’s oral GLP-1, orforglipron, led to significant weight loss and blood sugar reductions in a late-stage clinical trial.  In the phase 3 study, adults with obesity, were overweight and with Type 2 diabetes lost an average of 10.5% of…

Eversana, a pharmaceutical distributor and marketing company, has acquired a software company with plans to disrupt “the industry’s misaligned incentives and fragmented patient experiences,” according to an Aug. 26 news release.  The acquired firm, Waltz Health, offers prescription drug-pricing technology…

With drug costs rising, workforce shortages intensifying, and new therapies reshaping care delivery, pharmacy leaders are facing more complexity — and responsibility — than ever. That’s why Becker’s is bringing together hundreds of health plan leaders to transform the industry.…

AbbVie is acquiring Gilgamesh Pharmaceuticals’ lead drug candidate bretisilocin, used to treat moderate to severe major depressive disorder, for up to $1.2 billion.  Bretisilocin is a psychedelic compound that targets the 5-HT2A receptor and releases serotonin, according to an Aug.…

OptumRx, a UnitedHealth subsidiary, is tracking three new drugs this year: 

Heading into 2026, pharmacy leaders expect to see operations transformed, including shifts in Medicare pricing reform, artificial intelligence and expanding clinical responsibilities.  Here are responses from five pharmacy leaders who were asked: How do you anticipate your pharmacy functions will…